26 August 2020 in Lab on a Chip
Development of organoids and microfluidic on-chip models has enabled studies of organ-level disease pathophysiologies in vitro. However, current lung-on-a-chip platforms are primarily monolayer epithelial–endothelial co-cultures, separated by a thin membrane, lacking microvasculature-networks or interstitial-fibroblasts. Here we report the design, microfabrication, and characterization of a unique microphysiological on-chip device that recapitulates the human lung interstitium–airway interface through a 3D vascular network, and normal or diseased fibroblasts encapsulated within a fibrin-collagen hydrogel underneath an airlifted airway epithelium. By incorporating fibroblasts from donors with idiopathic pulmonary fibrosis (IPF), or healthy-donor fibroblasts treated with TGF-β1, we successfully created a fibrotic, alpha smooth muscle actin (αSMA)-positive disease phenotype which led to fibrosis-like transformation in club cells and ciliated cells in the airway. Using this device platform, we further modeled the cystic fibrosis (CF) epithelium and recruitment of neutrophils to the vascular networks. Our results suggest that this microphysiological model of the human lung could enable more pathophysiologically relevant studies of complex pulmonary diseases.
1 March 2021 in Biomaterials
1 February 2016 in Molecular Cell
15 April 2016 in Journal of Materials Chemistry B
The bone marrow (BM) niche of hematopoietic stem and progenitor cells (HSPCs) is critical for maintaining homeostasis of the hematopoietic system in vivo. It also plays a critical role in many diseases, from cancer metastases to immune dysfunctions. While this microenvironment is well studied, we still do not have a full understanding of bone marrow functions and the HSPC niche. Reconstructing the bone marrow microenvironment in vitro using biomaterials has the potential to further our understanding of the complex HSPC niche, provide new insights on how various cells function within these niches, how complex disease processes happens within the BM, and also serve as a tool for more efficient generation of high quality, therapeutic hematopoietic and mesenchymal cells. Many synthetic and natural materials have been used to replicate the known physical and biochemical properties of bone marrow. Here we review key components and considerations for designing materials to engineer bone marrow niches and study HSPC behavior and disease pathologies. We also provide future perspectives on areas where new knowledge must be gained to achieve the scientific and clinical potential of materials-driven bone marrow niche development.
10 July 2013 in Proteins: Structure, Function, and Bioinformatics